Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder (Q37397705)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2016

Language	Label	Description	Also known as
English	Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder	scientific article published on December 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

0 references

bipolar disorder

1 reference

based on heuristic

inferred from title

7

object named as

Olav Spigset

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ole A. Andreassen

6

object named as

Ole A Andreassen

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Katrine Kveli Fjukstad

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Anne Engum

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Stian Lydersen

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ingrid Dieset

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nils Eiel Steen

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 December 2016

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Journal of Clinical Psychopharmacology

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

36

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

615-620

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Understanding and Improving Cardiovascular Health: An Update on the American Heart Association's Concept of Cardiovascular Health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Comparison of methods for imputing limited-range variables: a simulation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Weight considerations in psychotropic drug prescribing and switching

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Cardiovascular morbidity and mortality in bipolar disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Metabolic syndrome associated with schizophrenia and atypical antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Metabolic drug interactions with newer antipsychotics: a comparative review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

6 September 2017

Effects of paroxetine and sertraline on low-density lipoprotein cholesterol: an observational cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Paroxetine-induced increase in LDL cholesterol levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Increased cholesterol levels after paroxetine treatment in patients with panic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Increased cholesterol levels during paroxetine administration in healthy men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Effects of selective serotonin reuptake inhibitors on cholesterol levels in patients with panic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Metabolic syndrome in patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

Changes in weight during a 1-year trial of fluoxetine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

2 September 2018

The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098465

5 November 2018

Adults with mood disorders have an increased risk profile for cardiovascular disease within the first 2 years of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/27749681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/27749681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/27749681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/27749681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/JCP.0000000000000582

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37397705&oldid=2227813848"